FDA approves groundbreaking sickle cell anemia treatment

The FDA has approved a groundbreaking cure for sickle cell anemia called Casgevy which uses the gene-editing tool CRISPR. NBC News’ Rehema Ellis has more details on the new hope for those suffering with the debilitating blood disorder.

» Subscribe to NBC News: https://www.youtube.com/user/NBCNews

NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

Connect with NBC News Online!
Breaking News Alerts: https://link.nbcnews.com/join/5cj/breaking-news-signup?cid=sm_npd_nn_yt_bn-clip_190621
Visit NBCNews.Com: https://www.nbcnews.com/
Find NBC News on Facebook: https://www.facebook.com/NBCNews
Follow NBC News on Twitter: https://twitter.com/NBCNews
Get more of NBC News delivered to your inbox: nbcnews.com/newsletters

#SickleCellAnemia #GeneEditing #FDA